12:00 AM
Jan 07, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

AciPhex regulatory update

On Dec. 11, 2012, Eisai said FDA granted pediatric exclusivity for Aciphex rabeprazole, which extends patent protection for the drug by 6 months to Nov. 8, 2013. A 20 mg tablet formulation of Aciphex is approved to treat daytime and...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >